by Virtus | Mar 21, 2026 | Early-Stage Respiratory Drug Development
Outsourcing respiratory research in the UK is a common strategy for biotech and pharmaceutical companies seeking specialist expertise in preclinical respiratory studies. Respiratory drug development often requires disease-specific models, in vivo respiratory studies,...
by Virtus | Feb 4, 2026 | Early-Stage Respiratory Drug Development
Early stage respiratory drug development focuses on evaluating therapeutic feasibility, biological activity, and translational relevance before compounds progress into clinical investigation. At this stage, preclinical respiratory studies are designed to generate...
